Truth or Consequences Brewery Tour Featuring MillionBat Migration Draws Tourism Interest US Military Drill in Venezuela Raises Geopolitical Stakes Amid Political Transition AIADMK Chief Slams TN Governments Crop Loan Waiver as Scientific Deception Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks Dating Startups Target Fake Profiles with Verification Services Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report WaFd Inc WAFD Q1 2026 Earnings Strong EPS Beat Drives Confidence Amid Steady Performance KDP Q1 2026 Earnings Earnings Beat Drives Modest Stock Uptick Amid Revenue Disclosures Uncertainty ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline MATW Q1 2026 Earnings Stellar EPS Surprise Lifts Investor Sentiment APA Q1 2026 Earnings Strong EPS Beat of 2185 Drives Positive Stock Reaction EQT Q1 2026 Earnings Earnings Beat Surprise Amidst Energy Market Volatility Lyell Immunopharma LYEL Holds Steady With Modest Gains Amid Technical Consolidation Inogen INGN Sees Mild Uptick Consolidates Near Key Resistance Arcutis Biotherapeutics ARQT Edges Lower as Shares Test Key Support Levels Hut 8 HUT Surges 89 as Momentum Builds Toward Key Resistance Ernexa Therapeutics Warrants ERNAW Slide Marginally to 015 Testing Key Support Zone Zydus Lifesciences Revises Share Buyback Price Increased to Rs 1260 Repurchase Size Reduced DHR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency USGOW Tumbles 34 to 005 as Warrants Test Critical Support Level Goldman Sachs Edges Higher GS Tests Key Resistance Near 1000 Level Booz Allen Hamilton BAH Gains 156 Defense Contractor Approaches Key Resistance BristolMyers Squibb BMY Modestly Declines as Resistance Holds BitMine Immersion Technologies BMNR Under Pressure as Shares Slide 372 Capital City Bank Group CCBG Holds Steady Amid Modest Decline Key Levels in Focus Siddhi Acquisition Corp SDHI Holds Steady at 1039 as SPAC Waits for Catalyst CNS Pharmaceuticals CNSP Surges Over 7 as Biotech Momentum Builds